(3,3-dimethyl-2-oxo-4-{4-[2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethoxy]phenyl}cyclobutyl )acetic acid trifluoroacetate | 689259-68-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二氮杂萘
• 英文名称: (3,3-dimethyl-2-oxo-4-{4-[2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethoxy]phenyl}cyclobutyl )acetic acid trifluoroacetate
• 英文别名: 2-[3,3-Dimethyl-2-oxo-4-[4-[2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethoxy]phenyl]cyclobutyl]acetic acid;2,2,2-trifluoroacetic acid
• CAS: 689259-68-5
• 化学式: C₂HF₃O₂*C₂₄H₂₈N₂O₄
• 分子量: 522.521
• InChiKey: TXVIUQXTHOTCQC-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.48
• 重原子数：
  37
• 可旋转键数：
  7
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.46
• 拓扑面积：
  126
• 氢给体数：
  3
• 氢受体数：
  11

反应信息

• 作为产物：
  描述：

  3-(4-methoxyphenyl)-2,2-dimethylcyclobutanone 生成 (3,3-dimethyl-2-oxo-4-{4-[2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethoxy]phenyl}cyclobutyl )acetic acid trifluoroacetate
  参考文献：
  名称：

  Cycloalkyl alkanoic acids as integrin receptor antagonists derivatives

  摘要：

  本发明涉及一类由化学式I表示的化合物，或其药学上可接受的盐，包括化合物I的药物组合物，以及选择性地抑制或拮抗αvβ3和/或αvβ5整合素的方法。

  公开号：

  US06921767B2

文献信息

• Indole derivatives
  申请人：Yamasaki Noritsugu

  公开号：US20050171185A1

  公开（公告）日：2005-08-04

  A novel indole derivative or a salt thereof is provided, which is represented by the formula: wherein R 1 represents an aryl lower alkyl group, said aryl group may be substituted with one or more groups selected from the group consisting of a halogen atom, an aryl group, a heterocyclic group, an aryl lower alkyl group, an aryl lower alkenyl group, a halo-lower alkyl group, a lower cycloalkyl-lower alkoxy group, a lower cycloalkoxy-lower alkyl group, an aryl lower alkynyl group, an aryloxy lower alkyl group, an aryl lower alkoxy group, a lower alkylthio group, a lower alkoxy group, and an alkenyl group; and R 2 represents a lower alkyl group, a lower alkenyl group, an aryl group, or a heterocyclic group, each of which may be substituted with a hydrogen atom, a lower alkyl group, a lower alkenyl group, or an aryl group. The compound of the present invention has blood sugar level-depressing activity and PDE5-inhibiting activity, and is useful as medicine.

  本发明提供了一种新的吲哚衍生物或其盐，其表示为以下公式：其中，R1表示芳基低烷基基团，所述芳基基团可以用以下一种或多种基团替代：卤原子、芳基基团、杂环基团、芳基低烷基基团、芳基低烯基基团、卤代低烷基基团、低环烷基低烷氧基团、低环烷氧基低烷基基团、芳基低炔基基团、芳氧基低烷基基团、芳基低烷氧基团、低烷基硫基团、低烷氧基团和烯基基团；R2表示低烷基基团、低烯基基团、芳基基团或杂环基团，每个基团可以用氢原子、低烷基基团、低烯基基团或芳基基团替代。本发明化合物具有降低血糖水平的活性和PDE5抑制活性，并可用作药物。
• INDOLE DERIVATIVES
  申请人：FUJISAWA PHARMACEUTICAL CO., LTD.

  公开号：EP1070705A1

  公开（公告）日：2001-01-24

  Novel indole derivatives represented by formula (I) or salts thereof, wherein R1 is aryl-substituted lower alkyl in which the aryl may be substituted by at least one member selected among halogen atoms, aryls, heterocyclic groups, aryl-substituted lower alkyls, aryl-substituted lower alkenyls, lower haloalkyls, (lower cycloalkyl)-substituted lower alkyloxys, (lower cycloalkyloxy)-substituted lower alkyls, aryl-substituted lower alkynyls, aryloxy-substituted lower alkyls, aryl-substituted lower alkyloxys, lower alkylthios, lower alkyloxys, and alkenyls; and R2 is a lower alkyl, lower alkenyl, aryl, or heterocyclic group optionally substituted by halogeno, lower alkyl, lower alkenyl, or aryl. These compounds have a hypoglycemic activity and a PDE5 inhibitory activity and are useful as a drug.

  低级卤代烷基、（低级环烷基）取代的低级烷氧基、（低级环烷氧基）取代的低级烷基、芳基取代的低级炔基、芳氧基取代的低级烷基、芳基取代的低级烷氧基、低级烷硫基、低级烷氧基和烯基；R2 是可选被卤素、低级烷基、低级烯基或芳基取代的低级烷基、低级烯基、芳基或杂环基团。这些化合物具有降血糖活性和 PDE5 抑制活性，可用作药物。
• US6921767B2
  申请人：——

  公开号：US6921767B2

  公开（公告）日：2005-07-26
• Cycloalkyl alkanoic acids as integrin receptor antagonists derivatives
  申请人：——

  公开号：US20040092538A1

  公开（公告）日：2004-05-13

  The present invention relates to a class of compounds represented by the Formula I 1 or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising compounds of the Formula I, and methods of selectively inhibiting or antagonizing the &agr; v &bgr; 3 and/or &agr; v &bgr; 5 integrin.

  本发明涉及一类由公式I代表的化合物 1 或其药用可接受的盐，包含公式I化合物的药物组合物，以及选择性地抑制或拮抗α v β 3 和/或α v β 5 整合素的方法。